Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001704633 | SCV000570835 | likely benign | not provided | 2022-10-12 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Genetic Services Laboratory, |
RCV000481535 | SCV000596386 | uncertain significance | not specified | 2015-11-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000887200 | SCV001030746 | benign | Pyruvate dehydrogenase E1-alpha deficiency | 2023-09-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001704633 | SCV004698563 | likely benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | PDHA1: BS2 |
Ambry Genetics | RCV004023155 | SCV005003717 | likely benign | Inborn genetic diseases | 2021-12-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001834564 | SCV002076941 | likely benign | Pyruvate dehydrogenase complex deficiency | 2020-03-26 | no assertion criteria provided | clinical testing |